Patrick Daly

Cancer Nursing Today nonprod

Steroid-refractory (SR) active graft-versus-host disease (aGVHD) is a serious complication of allogeneic hematopoietic stem-cell transplant (HCT) in patients with hematological malignancies. <a href="https://cancernursingtoday.com/post/exploring-ecps-mechanism-of-action-against-gvhd">Extracorporeal photopheresis</a> (ECP), a process of collecting blood and altering separated-out white blood cells, is a novel therapy that has shown promise in treating GVHD with minimal toxicity.<h3>ECP Improves Overall Survival in HCT Recipients</h3>In a study, published in Bone Marrow Transplantation, researchers evaluated patients who underwent allogeneic HCT and found that ECP was associated with improved overall survival (OS).The study included 103 retrospective patients with SR aGVHD. Of those patients, 79 received ECP and 24 did not. Baseline aGVHD grades and total organ involvement at onset of aGVHD and treatment initiation were comparable between the groups, the authors added.Of note, researchers reported patients in the ECP group had improved OS (P=.01), disease- free survival (P=.008), lower relapse (P=.05), similar nonrelapse mortality, and shorter hospital stays in the 180 days following aGVHD onset (20 vs 38; P=.03) compared with patients who did not receive ECP.Variables influencing OS included:<ul>
<li>CMV positive versus CMV negative (hazard ratio [HR], 2.34; 95% CI, 1.16-4.69)</li>
<li>Myeloablative versus nonmyeloablative conditioning (HR, 0.39; 95% CI, 0.20-0.75)</li>
<li>Use of ECP versus no ECP (HR, 0.39; 95% CI, 0.20-0.75)</li>
</ul>&ldquo;The use of ECP in the treatment of SR aGVHD results in improved overall survival secondary to lower relapse rates compared with other therapeutic modalities that do not incorporate ECP,&rdquo; the authors summarized.Read More&nbsp;<a href="https://cancernursingtoday.com/page/gvhd">Research and Topics Selected for Nurses Caring for GVHD</a>

Extracorporeal Photopheresis in SR aGVHD Treatment

GVHD

Patients with steroid-refractory acute graft-versus-host disease who received extracorporeal photopheresis had better survival than those who did not.

About Us

Editorial Policy

Authors

Advertising

eNewsletters

Contact Us

Contribute

Calendar of Events

Career Center

Blood Cancers Today

GU Oncology Now

DocWire News

MashupMD

Urban Health Today

Breast Cancer

Colorectal Cancer

GI Cancer

GU Cancer

Gynecologic Cancer Awareness Month

Gyn-Onc

Blood Cancer Awareness Month

Leukemia

Lymphoma

Myeloproliferative Neoplasms

Multiple Myeloma

Myelodysplastic Syndrome

Myelofibrosis

Sickle Cell

Hem/Onc

Professional Development

Patient Voice

Lung Cancer

Skin Cancer

Other Tumor Types

News

Treatment

More

Conferences

Calendar

CARE Award

Best Practices

Expert Interviews

Subscribe